Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04299178 · ClinicalTrials.gov registry record
Usability Evaluation of a Portable Oxygen Concentrator
A clinical trial, sponsored by Belluscura.
- Completed
- Registry status
- 18
- Enrollment target
NCT04299178: Completed study, sponsored by Belluscura.
NCT04299178 is a clinical trial that has completed, run by Belluscura. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04299178 has completed, sponsored by Belluscura.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
This study evaluates how well an individual can put together and use a Portable Oxygen Concentrator (POC) by following the instructions in the User Manual.
Primary Outcome
A subject who is able to follow the instructions to correctly assemble and receive oxygen through the X-PLO2R POC will be considered a study pass.A subject who is not able to follow the instructions and does not correctly assemble and receive oxygen through the X-PLO2R POC will be considered a study fail.
Interventions
- DEVICE X-PLO2R POC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2020-02-10 |
| Est. Completion | 2020-02-14 |
What the finished NCT04299178 record still lists
NCT04299178 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which X-PLO2R POC is the first listed.
NCT04299178 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04299178 about?
NCT04299178 is a clinical study titled "Usability Evaluation of a Portable Oxygen Concentrator". This study evaluates how well an individual can put together and use a Portable Oxygen Concentrator (POC) by following the instructions in the User Manual.
What is the current status of trial NCT04299178?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2020-02-10. Estimated completion is 2020-02-14.
What interventions are being tested in trial NCT04299178?
The interventions under investigation include: X-PLO2R POC (DEVICE).
Who is sponsoring clinical trial NCT04299178?
This trial is sponsored by Belluscura, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI